Magnetic nanoparticles excited by alternating magnetic fields (AMF) have demonstrated effective tumor-specific hyperthermia. This treatment is effective as a monotherapy as well as a therapeutic adjuvant to chemotherapy and radiation. Iron oxide nanoparticles have been shown, so far, to be non-toxic, as are the exciting AMF fields when used at moderate levels. Although higher levels of AMF can be more effective, depending on the type of iron oxide nanoparticles use, these higher field strengths and/or frequencies can induce normal tissue heating and toxicity. Thus, the use of nanoparticles exhibiting significant heating at low AMF strengths and frequencies is desirable. Our preliminary experiments have shown that the aggregation of magnetic nanoparticles within tumor cells improves their heating effect and cytotoxicity per nanoparticle. We have used transmission electron microscopy to track the endocytosis of nanoparticles into tumor cells (both breast adenocarcinoma (MTG-B) and acute monocytic leukemia (THP-1) cells). Our preliminary results suggest that nanoparticles internalized into tumor cells demonstrate greater cytotoxicity when excited with AMF than an equivalent heat dose from excited external nanoparticles or cells exposed to a hot water bath. We have also demonstrated that this increase in SAR caused by aggregation improves the cytotoxicity of nanoparticle hyperthermia therapy in vitro.
INTRODUCTION
Gilchrist, et al demonstrated in 1957 that magnetic nanoparticles (mNP) could be used to heat lymph nodes when alternating magnetic fields were applied [1] . Since those experiments, work has been undertaken to attempt to use mNP to treat both rodent [2] , [3] and human tumors [4] , [5] . Magnetic nanoparticle hyperthermia therapy (mNPHT) has become a promising new treatment for neoplasms [6] .
One of the challenges of mNPHT is that the AMF used to activate the mNP can induce currents in normal tissues, which cause toxicity [6] . One of the goals of mNPHT, then, is to allow for activation of mNP at field strengths and frequencies that are not toxic. To achieve this goal, the heating rate of mNP at a given frequency and field strength must be increased. By changing the composition of the magnetic core [7] and coating [8] of the mNP, this goal can be achieved. In this report, we explore the effect of nanoparticle encapsulation within tumor cells on the heating rate of the mNP and on the cytotoxicity of mNPHT. 
Tumor Cells
Used in these studies are the MTG-B murine breast adenocarcinoma cell line characterized by Clifton and Yatvin [9] and the THP-1 human acute monocytic leukemia cell line (ATCC, Manassas, VA). The THP-1 cells are non-adherent cells and were maintained in Falcon cell culture flasks (BD Biosciences, Bedford, MA) at 10 5 to 5*10 5 cells/ml at 37°C and 5% CO 2 in a Queue Systems incubator (Kendro Laboratory Products, Asheville, NC). The MTG-B cells are adherent cells and they were maintained in surface-treated Falcon cell culture flasks (BD Biosciences, Bedford, MA) at 20-80% confluence under the same conditions as the THP-1 cells. The MTG-B cell culture medium used was Alpha Minimum Essential Medium (Alpha MEM, HyClone Laboratories, Inc.) with 10% fetal bovine serum (HyClone Laboratories, Inc.), 1% L-glutamine (Mediatech, Inc.) and 1% penicillin-streptomycin (HyClone Laboratories, Inc.). The THP-1 cell culture medium used was RPMI-1640 Medium (ATCC) with 0.5 mM 2-mercaptoethanol (Sigma Aldrich Co., St. Louis, Mo), 10% fetal bovine serum (HyClone Laboratories) and 1% penicillin-streptomycin (HyClone Laboratories, Inc.).
Nanoparticles
In these studies, we used BNF nanoparticles (product number 10-00-801, Micromod Partikeltechnologie GmBH, Rostock, Germany). These mNP are composed of a hematite core surrounded with crystals of average diameter of approximately 20 nm (total core diameter approximately 40 nm) and a hydroxyethyl starch shell to a final average hydrodynamic diameter of 117 nm. The mNP were concentrated to a final particle concentration of 44 mg/ml and iron concentration of 28 mg/ml.
AMF-Generation Equipment
A 16-turn solenoidal coil with an inner diameter of 2 cm and an outer diameter of 3.2 cm composed of hollow copper tubing was used to generate AMF. The AMF coil was powered at 163 kHz by a TIG 10/300 generator (Huttinger Elektronik GmbH, Freiburg, Germany). The AMF coil and generator were cooled by a chiller (Tek-Temp Instruments, Croydon PA) operating at 20°C and four gallons per minute.
Methods

Specific Absorption Rate (SAR) Measurements
Seven mg Fe of mNP were suspended in 1 ml deionized water in 5 ml Falcon tubes (BD Biosciences, Bedford, MA). A fiber optic temperature probe with diameter 7 mm (FISO Inc., Quebec, Canada) was placed into the sample and an AMF of 400 Oe and 163 kHz was applied for one minute. Temperature was recorded and the SAR in watts/gram was calculated using the equation:
Where ∆ is the change in temperature of the steepest part of the heating curve, ∆ is the change in time during the change in temperature and [Fe] is the concentration of iron in the sample.
After the initial temperature measurement, an aliquot of 50 μl was removed from the SAR sample and fixed in 50 μl of 8% glutaraldehyde (Ted Pella, Inc.). Another 50 μl of 7 mg Fe/ml mNP in water was added to the SAR sample, along with 2 μl of 10 mg/ml Concanavalin A (Sigma-Aldrich Co.), a protein which has four subdomains which bind to sugars, such as those found in the hydroxyl-ethyl starch coating of the mNP. SAR measurement was then repeated, an aliquot fixed in glutaraldehyde, mNP replaced and Concanavalin A added. This procedure was repeated until the SAR of the sample increased ( Figure 1 ).
Sizing of mNP
The aliquots from the SAR experiments were resuspended in 10mM NaCl (Sigma-Aldrich) to a final concentration of 0.2 mg/ml mNP. Of these solutions, 1.25 mL of each was added to cuvettes (Sarstedt Inc., Newton, NC) and the mNP samples were sized with a Zetasizer Nano ZS (Malvern Instruments Inc., Westborough, MA) dynamic light scattering instrument.
Cell Uptake Studies
MTG-B cells were dissociated from the cell culture flasks using EDTA (Invitrogen 13151-014). They were then counted using trypan blue (Hyclone Laboratories, Inc.) and a hemacytometer (Fisher Scientific, Inc.), spun at 1500 RPM for 10 minutes and resuspended at 10 6 cells/ml MTG-B cell culture medium. MNP (17.9 μl) were added to 982 μl of the MTG-B cell suspension. Cells were then placed in the cell culture incubator. After 24 hours, cells were spun at 1500 RPM for 5 minutes, the cell medium was removed, and 4% glutaraldehyde in 0.1 M, pH 7.4 sodium cacodylate buffer (Ted Pella, Inc.) was added to the cell pellet.
THP-1 cells were suspended at 0.5*10 6 cells/ml in THP-1 cell culture medium. MNP (7.15 μl) were added to 993 μl of the THP-1 cell suspension and the solution was then placed in the cell incubator. After 24 hours, cells were spun at 1500 RPM for 5 minutes, the cell medium was removed, and 4% glutaraldehyde in 0.1 M, pH 7.4 sodium cacodylate buffer (Ted Pella, Inc.) was added to the cell pellet.
These samples were then processed for TEM, including staining with 4% osmium tetroxide (Ted Pella, Inc.) and 2% uranyl acetate (Ted Pella, Inc.), for one hour, each. The samples were embedded in Poly/Bed 812 resin (Polysciences, Inc., Warrington, PA) and 100 nm sections were cut using a Leica Ultra-Cut Microtome (Leica Microsystems GmbH, Wetzlar, Germany). TEM sections were imaged using a FEI Company Tecnai F20 FEG TEM operating at 100 kV.
Cell Cytotoxicity Studies
In all cytotoxicity experiments, heat dose was calculated using the CEM equation:
Where Δt is the time interval, T is the temperature and R = 0.25 when T is below 43°C and R = 0.45 when T is above 43°C [10] . The CEM equation normalizes thermal doses to the cytotoxic effect which would be expected for a certain number of minutes at 43°C.
MTG-B cells were suspended at 10 6 cells/ml and THP-1 cells at 0.5*10 6 as described in section 2.2.3., MNP (7.15 μl) were added to 993 μl of the MTG-B cells and 17.9 μl were added to 982 μl of the THP-1 cells in 1.5 ml SealRite microcentrifuge tubes (USA Scientific, Inc., Ocala, FL). There were a total of six samples of these types per cell line. An additional nine samples per cell line with the same volumes and concentrations of cells but lacking mNP were also prepared. MTG-B cells were allowed to incubate with mNP in the cell incubator for 24 hours and THP-1 cells were allowed to incubate with mNP in the cell incubator for 72 hours.
At the end of the 24 hour incubation period, two MTG-B cell samples were allowed to equilibrate to 32 ± 2°C and a fiber optic temperature probe (described in 2.2.1) was placed into each cell sample container. One sample was placed into a water bath at 38°C for ten minutes (mNP inc H 2 O) and the other (mNP inc AMF) placed into the AMF coil with the coil operating at 500 Oe for 10 minutes. Global temperatures within the entire sample were recorded and CEM calculated. Another two 993 μl samples of MTG-B cells in MTG-B medium suspended at 10 6 cells/ml had 7.15 μl of nanoparticles added. One sample (+ mNP H 2 O) was placed into a water bath at 38°C for ten minutes and the other (+ mNP AMF) placed into the AMF coil with the coil operating at 500 Oe for 10 minutes. Global temperatures within the entire sample were recorded and CEM calculated. One additional MTG-B sample had 7.15 μl of phosphate-buffered saline added and was placed in the 38°C water bath for 10 minutes. These five experimental groups were treated in triplicate.
At the end of the 72 hour incubation period, two THP-1 cell samples were allowed to equilibrate to 32 ± 2°C and a fiber optic temperature probe (described in 2.2.1) was placed into each cell sample container. Global temperatures within the entire sample were recorded. One sample was placed into a water bath at 38°C (mNP inc H 2 O) and the other (mNP inc AMF) placed into the AMF coil with the coil operating at 500 Oe until the sample in the coil reached a CEM of 60. 
CONCLUSIONS
Our preliminary data suggest that nanoparticle SAR is significantly increased by the addition of Concanavalin A to the mNP sample; the Concanavalin A causes mNP to aggregate. When the average hydrodynamic diameter of the aggregates is between 230 and 700 nm, as determined by dynamic light scattering, the SAR of the samples dramatically increases. As demonstrated with TEM, the size of aggregates of mNP within both MTG-B and THP-1 cells allowed to incubate with mNP for 24 hours are of approximately the same sizes required for increased mNP SAR to occur.
Our preliminary data also suggest that cancer cells containing mNP, following exposure to an AMF, demonstrate cytotoxicity in the absence of recordable cytotoxic temperatures. These preliminary results suggest that there is a mechanism other than mere global hyperthermia causing cytotoxicity when intracellular mNP are exposed to AMF. Other potential mechanisms of cytotoxicity include intracellular-only lethal hyperthermia and mechanical damage from mNP motion within cells.
THP-1 cells with internalized mNP demonstrate greater cytotoxicity than THP-1 cells associate with extracellular mNP when AMF is applied to the same CEM, suggesting the presence of a mechanism of cytotoxicity different than global hyperthermia.
In our future studies, we will explore cytotoxicity and mNP uptake kinetics in additional tumor cell types and at a larger range of CEM values.
